AXSM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $10,005,148.57

Axsome Therapeutics Insider Trading History Chart

Axsome Therapeutics Share Price & Price History

^$95.61

▲ +4.07 (4.45%)

As of 09/19/2024 01:30 PM ET

Days: 30 | 90 | 365

This diversified cannabis pioneer could make huge moves soon

From Greenlane | Ad

The cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start with diversification and experience. Founded in 2005, this company serves a diverse and expansive customer base with more than 8,000 retail locations, including licensed cannabis dispensaries, smoke shops, and specialty retailers.

Learn more here.

Axsome Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/11/2024	Mark E. Saad	Director	Sell	11,016	$91.31	$1,005,870.96	10,002
8/9/2024	Mark L. Jacobson	COO	Sell	47,739	$84.26	$4,022,488.14	5,783
5/29/2024	Mark L. Jacobson	COO	Sell	7,910	$74.31	$587,792.10	5,783
5/28/2024	Mark Coleman	Director	Sell	5,249	$75.21	$394,777.29	19,848
4/1/2024	Mark L. Jacobson	COO	Sell	24,662	$77.24	$1,904,892.88
3/14/2024	Roger Jeffs	Director	Sell	29,976	$69.70	$2,089,327.20	120,756
9/15/2023	Mark Coleman	Director	Sell	11,016	$75.19	$828,293.04	25,097
11/19/2021	Roger Jeffs	Director	Buy	3,950	$37.30	$147,335.00
11/18/2021	Nick Pizzie	CFO	Buy	527	$35.50	$18,708.50
11/17/2021	Mark E. Saad	Director	Buy	3,000	$34.53	$103,590.00

This Crypto Is Set to Explode in September

From Crypto 101 Media | Ad

With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Now, I'm about to reveal the #1 crypto for September 2024.

Go here to get full details on this crypto now.

SEC Filings (Institutional Ownership Changes) for Axsome Therapeutics (NASDAQ:AXSM)

81.49% of Axsome Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Axsome Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/16/2024	Point72 Asia Singapore Pte. Ltd.	584	$47K	0.0%	N/A	0.001%
8/27/2024	Clearbridge Investments LLC	106,767	$8.60M	0.0%	+19.5%	0.225%
8/27/2024	Dana Investment Advisors Inc.	19,724	$1.59M	0.1%	+3.7%	0.042%
8/26/2024	Teachers Retirement System of The State of Kentucky	11,354	$0.91M	0.0%	+17.1%	0.024%
8/16/2024	Perceptive Advisors LLC	459,111	$36.96M	0.9%	-58.5%	0.967%
8/16/2024	Quarry LP	3,200	$0.26M	0.1%	+77.8%	0.007%
8/16/2024	Northwestern Mutual Wealth Management Co.	335	$27K	0.0%	N/A	0.001%
8/16/2024	Creative Planning	8,365	$0.67M	0.0%	+15.9%	0.018%
8/16/2024	Algert Global LLC	3,105	$0.25M	0.0%	N/A	0.007%
8/15/2024	The Manufacturers Life Insurance Company	22,901	$1.84M	0.0%	+4.6%	0.048%
8/15/2024	Millennium Management LLC	739,819	$59.56M	0.0%	+1.4%	1.558%
8/15/2024	AQR Capital Management LLC	12,836	$1.03M	0.0%	-54.6%	0.027%
8/15/2024	Affinity Asset Advisors LLC	80,000	$6.44M	0.7%	-42.8%	0.168%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	584	$47K	0.0%	N/A	0.001%
8/15/2024	Point72 Europe London LLP	30,741	$2.48M	0.2%	N/A	0.065%
8/14/2024	Tri Locum Partners LP	306,513	$24.67M	6.2%	+198.4%	0.645%
8/14/2024	Bank of Montreal Can	10,531	$0.85M	0.0%	N/A	0.022%
8/14/2024	Hood River Capital Management LLC	549,066	$44.20M	0.9%	+5.4%	1.156%
8/14/2024	HighVista Strategies LLC	62,192	$5.01M	1.8%	+28.2%	0.131%
8/14/2024	ProShare Advisors LLC	7,707	$0.62M	0.0%	-20.7%	0.016%
8/14/2024	Profund Advisors LLC	6,871	$0.55M	0.0%	-23.8%	0.014%
8/13/2024	Sei Investments Co.	40,624	$3.27M	0.0%	+13.9%	0.086%
8/12/2024	XTX Topco Ltd	11,205	$0.90M	0.1%	+177.9%	0.024%
8/12/2024	Hsbc Holdings PLC	3,785	$0.30M	0.0%	-21.7%	0.008%
8/12/2024	Blair William & Co. IL	59,151	$4.76M	0.0%	-6.9%	0.125%
8/10/2024	Mutual of America Capital Management LLC	39,893	$3.21M	0.0%	-4.1%	0.084%
8/10/2024	Sofinnova Investments Inc.	310,198	$24.97M	1.3%	N/A	0.653%
8/9/2024	WINTON GROUP Ltd	8,823	$0.71M	0.0%	+156.6%	0.019%
8/8/2024	First Turn Management LLC	337,246	$27.15M	4.4%	-1.4%	0.710%
8/8/2024	State of New Jersey Common Pension Fund D	24,729	$1.99M	0.0%	-27.0%	0.052%
8/7/2024	Wedbush Securities Inc.	4,818	$0.39M	0.0%	-41.9%	0.010%
8/6/2024	Torray Investment Partners LLC	11,747	$0.95M	0.1%	+11.5%	0.025%
8/5/2024	Arizona State Retirement System	8,630	$0.70M	0.0%	+2.1%	0.018%
8/1/2024	Rhumbline Advisers	54,931	$4.42M	0.0%	+5.1%	0.116%
8/1/2024	Privium Fund Management B.V.	74,332	$5.87M	1.5%	-9.4%	0.156%
7/29/2024	Peregrine Capital Management LLC	87,373	$7.03M	0.2%	+1.4%	0.184%
7/29/2024	Principal Financial Group Inc.	6,554	$0.53M	0.0%	-32.9%	0.014%
7/26/2024	Iridian Asset Management LLC CT	126,905	$10.22M	2.3%	-1.5%	0.267%
7/26/2024	Bank of New York Mellon Corp	165,564	$13.33M	0.0%	+7.7%	0.349%
7/26/2024	AlphaCentric Advisors LLC	15,000	$1.21M	0.9%	-53.8%	0.032%
7/20/2024	China Universal Asset Management Co. Ltd.	5,580	$0.45M	0.1%	-38.7%	0.012%
7/20/2024	Hennion & Walsh Asset Management Inc.	64,685	$5.21M	0.3%	-6.9%	0.136%
7/18/2024	Assenagon Asset Management S.A.	33,969	$2.74M	0.0%	N/A	0.072%
7/17/2024	Oak Ridge Investments LLC	13,936	$1.12M	0.1%	-12.5%	0.029%
7/16/2024	Flower City Capital	3,000	$0.24M	0.2%	N/A	0.006%
7/12/2024	Lion Street Advisors LLC	8,315	$0.67M	0.2%	-30.3%	0.018%
7/11/2024	Wesbanco Bank Inc.	13,300	$1.07M	0.0%	+60.2%	0.028%
7/10/2024	CWM LLC	23,920	$1.93M	0.0%	-19.2%	0.050%
7/5/2024	DNB Asset Management AS	6,072	$0.49M	0.0%	+37.2%	0.013%
5/28/2024	Teachers Retirement System of The State of Kentucky	9,698	$0.77M	0.0%	N/A	0.020%
5/17/2024	Artal Group S.A.	76,837	$6.13M	0.2%	N/A	0.162%
5/17/2024	Comerica Bank	9,067	$0.72M	0.0%	+7,716.4%	0.019%
5/17/2024	Alethea Capital Management LLC	740,791	$59.12M	48.0%	-1.5%	1.560%
5/17/2024	Castleark Management LLC	32,200	$2.57M	0.1%	N/A	0.068%
5/16/2024	California State Teachers Retirement System	31,251	$2.49M	0.0%	-5.8%	0.066%
5/16/2024	Kennedy Capital Management LLC	19,483	$1.56M	0.0%	+46.0%	0.041%
5/15/2024	Bellevue Group AG	685,476	$54.70M	0.8%	+7.9%	1.443%
5/15/2024	Price T Rowe Associates Inc. MD	25,274	$2.02M	0.0%	-82.8%	0.053%
5/15/2024	Hood River Capital Management LLC	520,750	$41.56M	0.9%	+32.6%	1.096%
5/15/2024	Affinity Asset Advisors LLC	139,758	$11.15M	1.4%	+179.5%	0.294%
5/14/2024	EntryPoint Capital LLC	437	$35K	0.0%	N/A	0.001%
5/14/2024	Natixis	1,235	$99K	0.0%	+13.6%	0.003%
5/14/2024	Pitcairn Co.	4,674	$0.37M	0.0%	-5.8%	0.010%
5/14/2024	Healthcare of Ontario Pension Plan Trust Fund	138,300	$11.04M	0.0%	N/A	0.291%
5/14/2024	CANADA LIFE ASSURANCE Co	7,370	$0.59M	0.0%	+136.8%	0.016%
5/14/2024	American International Group Inc.	17,570	$1.40M	0.0%	-0.9%	0.037%
5/13/2024	Clearbridge Investments LLC	89,370	$7.13M	0.0%	N/A	0.188%
5/11/2024	Covestor Ltd	1,097	$88K	0.1%	+54,750.0%	0.002%
5/10/2024	Vanguard Group Inc.	3,740,278	$298.47M	0.0%	+1.2%	7.875%
5/10/2024	Tocqueville Asset Management L.P.	6,300	$0.50M	0.0%	-6.0%	0.013%
5/9/2024	Blair William & Co. IL	63,547	$5.07M	0.0%	+645.9%	0.134%
5/9/2024	State Board of Administration of Florida Retirement System	9,422	$0.75M	0.0%	-6.2%	0.020%
5/8/2024	ProShare Advisors LLC	9,724	$0.78M	0.0%	+9.0%	0.020%
5/8/2024	US Bancorp DE	133,505	$10.65M	0.0%	-6.9%	0.281%
5/8/2024	Russell Investments Group Ltd.	791	$63K	0.0%	+5,550.0%	0.002%
5/7/2024	Sei Investments Co.	35,654	$2.85M	0.0%	+8.2%	0.075%
5/7/2024	SG Americas Securities LLC	15,104	$1.21M	0.0%	+605.5%	0.032%
5/2/2024	Mutual of America Capital Management LLC	41,620	$3.32M	0.0%	+20.4%	0.088%
5/2/2024	Iridian Asset Management LLC CT	128,842	$10.28M	2.0%	-6.9%	0.271%
5/1/2024	Janney Montgomery Scott LLC	5,780	$0.46M	0.0%	+9.5%	0.012%
5/1/2024	BNP Paribas Financial Markets	82,544	$6.59M	0.0%	+323.8%	0.174%
5/1/2024	Oak Ridge Investments LLC	15,930	$1.27M	0.1%	+2.7%	0.034%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	15,249	$1.22M	0.0%	-15.1%	0.032%
4/30/2024	Privium Fund Management B.V.	82,032	$6.55M	1.8%	+13.9%	0.173%
4/29/2024	Principal Financial Group Inc.	9,773	$0.78M	0.0%	+2.9%	0.021%
4/29/2024	China Universal Asset Management Co. Ltd.	9,103	$0.73M	0.1%	+66.3%	0.019%
4/26/2024	Peregrine Capital Management LLC	86,135	$6.87M	0.2%	+1.6%	0.182%
4/25/2024	Lindbrook Capital LLC	83,768	$6.69M	0.6%	-0.4%	0.177%
4/25/2024	WCM Investment Management LLC	111,590	$8.91M	0.0%	+6.5%	0.236%
4/23/2024	Wesbanco Bank Inc.	8,300	$0.66M	0.0%	N/A	0.018%
4/23/2024	Raymond James Financial Services Advisors Inc.	17,321	$1.38M	0.0%	-4.5%	0.037%
4/17/2024	Hennion & Walsh Asset Management Inc.	69,483	$5.55M	0.3%	+14.6%	0.147%
4/15/2024	Janiczek Wealth Management LLC	1,213	$97K	0.0%	N/A	0.003%
4/10/2024	Yarbrough Capital LLC	5,054	$0.40M	0.0%	N/A	0.011%
3/11/2024	Vanguard Group Inc.	3,696,766	$294.23M	0.0%	-0.9%	7.804%
3/5/2024	Wellington Management Group LLP	239,819	$19.09M	0.0%	+1.0%	0.506%
2/26/2024	Perceptive Advisors LLC	1,038,019	$82.62M	1.9%	+115.5%	2.194%
2/22/2024	Sierra Summit Advisors LLC	9,224	$0.73M	0.2%	N/A	0.019%
2/15/2024	PFM Health Sciences LP	467,427	$37.20M	2.2%	-10.7%	0.988%
2/15/2024	Great Point Partners LLC	4,963	$0.40M	0.1%	N/A	0.010%

Data available starting January 2016

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder; and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-07, an investigational medicine that has completed Phase III trials for the acute treatment of migraine; AXS-12, an investigational medicine, which is in Phase III trial to treat narcolepsy; AXS-14, a selective and potent norepinephrine reuptake inhibitor that has completed Phase III trial for the treatment of fibromyalgia and other conditions; and solriamfetol, a dual-acting dopamine and norepinephrine reuptake inhibitor, which has completed a Phase 2 trial for treating attention-deficit/hyperactivity disorder, and is in phase 2 major depressive, binge eating, and shift work disorder. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

Today's Range

Now: $95.61

$91.80

$95.77

50 Day Range

MA: $87.47

$82.14

$95.56

52 Week Range

Now: $95.61

$55.02

$98.40

Volume

134,252 shs

Average Volume

652,914 shs

Market Capitalization

$4.54 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25

Who are the company insiders with the largest holdings of Axsome Therapeutics?: Axsome Therapeutics' top insider investors include:
Roger Jeffs (Director)
Mark Coleman (Director)
Mark E Saad (Director)
Mark L Jacobson (COO)
Mark L Jacobson (COO)
Learn More about top insider investors at Axsome Therapeutics.
Who are the major institutional investors of Axsome Therapeutics?: Axsome Therapeutics' top institutional shareholders include:
Millennium Management LLC — 1.56%
Hood River Capital Management LLC — 1.16%
Perceptive Advisors LLC — 0.97%
First Turn Management LLC — 0.71%
Sofinnova Investments Inc. — 0.65%
Tri Locum Partners LP — 0.65%
Learn More about top institutional investors of Axsome Therapeutics stock.
Which institutional investors are selling Axsome Therapeutics stock?: During the last quarter, AXSM stock was sold by these institutional investors:
Perceptive Advisors LLC
Affinity Asset Advisors LLC
AlphaCentric Advisors LLC
AQR Capital Management LLC
State of New Jersey Common Pension Fund D
Privium Fund Management B.V.
CWM LLC
First Turn Management LLC
During the last year, company insiders that have sold Axsome Therapeutics company stock include:
Roger Jeffs (Director)
Mark Coleman (Director)
Mark E Saad (Director)
Mark L Jacobson (COO)
Mark L Jacobson (COO)
Learn More investors selling Axsome Therapeutics stock.
Which institutional investors are buying Axsome Therapeutics stock?: Within the previous quarter, AXSM stock was bought by institutional investors including:
Sofinnova Investments Inc.
Tri Locum Partners LP
Assenagon Asset Management S.A.
Point72 Europe London LLP
Hood River Capital Management LLC
Clearbridge Investments LLC
HighVista Strategies LLC
Bank of New York Mellon Corp